Stock Updates

Is this Large Market Cap Stock target price reasonable for Bristol-Myers Squibb Company (NYSE:BMY)?

The company in question is, Bristol-Myers Squibb Company (NYSE:BMY) currently with a stock price of 76.01 (1.27% today). The market cap for Bristol-Myers Squibb Company is 125275.14, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Bristol-Myers Squibb Company is 77. Currently Bristol-Myers Squibb Company is trading with a P/E of 80.19, and a forward P/E of 23.15. Average volume for Bristol-Myers Squibb Company is 5921.05 and so far today it is 1941423.

Performance in the last year for Bristol-Myers Squibb Company has been 19.45%. For EPS growth, Bristol-Myers Squibb Company has seen a growth of -22.30%, and is looking to grow in the next year to 25.42%. More long term stats show that EPS growth has been -12.20% over the last five years and could be 23.21% for the next five years. Bristol-Myers Squibb Company has seen sales growth quarter over quarter at 8.70%, with EPS growth quarter over quarter at 0.50%. The 20-day simple moving average is 4.33%, with the 200-day simple moving average coming to 13.57%.

Since the IPO date for Bristol-Myers Squibb Company on the 6/1/1972, Bristol-Myers Squibb Company has seen performance year to date to be 10.35%. With Bristol-Myers Squibb Company trading at 76.01, the dividend yield is 2.03%, and the EPS is 0.94.

So could Bristol-Myers Squibb Company, be undervalued? Well as said before P/E is 80.19. The PEG is 3.46, P/S is 7.41 and the P/B is at 8.71. The P/cash is 29.09, with P/free cash flow at *TBA.

Bristol-Myers Squibb Company ability to deal with debt shows that the current ratio is 1.5, and the quick ratio is 1.3. This is with long term debt/equity at 0.46, and total debt/equity at 0.47.

In terms of margins, Bristol-Myers Squibb Company has a gross margin of 76.00%, an operating margin of 11.60% and a profit margin of 9.30%.Payout ratio for Bristol-Myers Squibb Company is 159.00%. Return on assets come to 4.90% with return on investment coming to 4.60%.

Insider ownership for Bristol-Myers Squibb Company, is at 0.10% and institutional ownership comes to 74.40%. Outstanding shares are at 1669. While shares float is 1666.37. The float short is currently 0.96%, and short ratio is 2.71.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment